The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Chronic Bronchitis and Chronic Obstructive Pulmonary Disease
Open accessAbstract
Chronic bronchitis (CB) is a common but variable phenomenon in chronic obstructive pulmonary disease (COPD). It has numerous clinical consequences, including an accelerated decline in lung function, greater risk of the development of airflow obstruction in smokers, a predisposition to lower respiratory tract infection, higher exacerbation frequency, and worse overall mortality. CB is caused by overproduction and hypersecretion of mucus by goblet cells, which leads to worsening airflow obstruction by luminal obstruction of small airways, epithelial remodeling, and alteration of airway surface tension predisposing to collapse. Despite its clinical sequelae, little is known about the pathophysiology of CB and goblet cell hyperplasia in COPD, and treatment options are limited. In addition, it is becoming increasingly apparent that in the classic COPD spectrum, with emphysema on one end and CB on the other, most patients lie somewhere in the middle. It is known now that many patients with severe emphysema can develop CB, and small airway pathology has been linked to worse clinical outcomes, such as increased mortality and lesser improvement in lung function after lung volume reduction surgery. However, in recent years, a greater understanding of the importance of CB as a phenotype to identify patients with a beneficial response to therapy has been described. Herein we review the epidemiology of CB, the evidence behind its clinical consequences, the current understanding of the pathophysiology of goblet cell hyperplasia in COPD, and current therapies for CB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Self-citationCalverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Molet, S., Hamid, Q., Davoineb, F., Nutku, E., Tahaa, R., Pagé, N., Olivenstein, R., Elias, J., & Chakir, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117929 · Cited by 953
Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031402 · Cited by 887
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
T-cell subsets (Th1 versus Th2)
Romagnani, S. (2000) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62426-x · Cited by 815
Vestbo, J., Prescott, E., & Lange, P. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630597 · Cited by 752
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Bhowmik, A. (2000) · Thorax · doi:10.1136/thorax.55.2.114 · Cited by 730
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Kohansal, R., Martinez-Camblor, P., Agustí, A., Buist, A. S., Mannino, D. M., & Soriano, J. B. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0047oc · Cited by 654
LUNDBÄCK, B., LINDBERG, A., LINDSTRÖM, M., RÖNMARK, E., JONSSON, A. C., JÖNSSON, E., LARSSON, L.-G., ANDERSSON, S., SANDSTRÖM, T., & LARSSON, K. (2003) · Respiratory Medicine · doi:10.1053/rmed.2003.1446 · Cited by 643
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities
Miravitlles, M., Soriano, J. B., Garcia-Rio, F., Munoz, L., Duran-Tauleria, E., Sanchez, G., Sobradillo, V, & Ancochea, J. (2009) · Thorax · doi:10.1136/thx.2009.115725 · Cited by 640
Mannino, D. M. (2003) · Thorax · doi:10.1136/thorax.58.5.388 · Cited by 639
Fabbri, L. M., Calverley, P. M., Izquierdo-Alonso, J. L., Bundschuh, D. S., Brose, M., Martinez, F. J., & Rabe, K. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61252-6 · Cited by 614
Chen, Y., Thai, P., Zhao, Y.-H., Ho, Y.-S., DeSouza, M. M., & Wu, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210429200 · Cited by 577
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M. E., Yancey, S. W., Zakes, B. A., Rickard, K. A., & Anderson, W. H. (1999) · Chest · doi:10.1378/chest.115.4.957 · Cited by 520
Quality of life changes in COPD patients treated with salmeterol.
Jones, P. W., & Bosh, T. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105068 · Cited by 494
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I
O'Donnell, A. E., Barker, A. F., Ilowite, J. S., & Fick, R. B. (1998) · Chest · doi:10.1378/chest.113.5.1329 · Cited by 443
Oxidants/Antioxidants and COPD
MacNee, W. (2000) · Chest · doi:10.1378/chest.117.5_suppl_1.303s-a · Cited by 421
Gender Bias in the Diagnosis of COPD
Chapman, K. R., Tashkin, D. P., & Pye, D. J. (2001) · Chest · doi:10.1378/chest.119.6.1691 · Cited by 401
Clinical relevance of airway remodelling in airway diseases
James, A. L., & Wenzel, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00146905 · Cited by 365
Zheng, J.-P., Kang, J., Huang, S.-G., Chen, P., Yao, W.-Z., Yang, L., Bai, C.-X., Wang, C.-Z., Wang, C., Chen, B.-Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60869-7 · Cited by 358
The occupational burden of chronic obstructive pulmonary disease
Trupin, L., Earnest, G., San Pedro, M., Balmes, J. R., Eisner, M. D., Yelin, E., Katz, P. P., & Blanc, P. D. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00094203 · Cited by 347
Burgel, P.-R., Nesme-Meyer, P., Chanez, P., Caillaud, D., Carré, P., Perez, T., & Roche, N. (2009) · Chest · doi:10.1378/chest.08-2062 · Cited by 346
SAETTA, M., TURATO, G., BARALDO, S., ZANIN, A., BRACCIONI, F., MAPP, C. E., MAESTRELLI, P., CAVALLESCO, G., PAPI, A., & FABBRI, L. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9907080 · Cited by 342
Di Stefano, A., Caramori, G., Gnemmi, I., Contoli, M., Vicari, C., Capelli, A., Magno, F., D'Anna, S. E., Zanini, A., Brun, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03965.x · Cited by 336
The Chronic Bronchitic Phenotype of COPD
Kim, V., Han, M. K., Vance, G. B., Make, B. J., Newell, J. D., Hokanson, J. E., Hersh, C. P., Stinson, D., Silverman, E. K., & Criner, G. J. (2011) · Chest · doi:10.1378/chest.10-2948 · Cited by 323
Self-citationde Marco, R., Accordini, S., Cerveri, I., Corsico, A., Antó, J. M., Künzli, N., Janson, C., Sunyer, J., Jarvis, D., Chinn, S., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-381oc · Cited by 306
The stability of peripheral airways
Macklem, P. T., Proctor, D. F., & Hogg, J. C. (1970) · Respiration Physiology · doi:10.1016/0034-5687(70)90015-0 · Cited by 303
The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation
Kikly, K., Liu, L., Na, S., & Sedgwick, J. D. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.008 · Cited by 303
Cystic fibrosis: a disease of vulnerability to airway surface dehydration
Boucher, R. C. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.05.001 · Cited by 273
Hattotuwa, K. L., Gizycki, M. J., Ansari, T. W., Jeffery, P. K., & Barnes, N. C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105025 · Cited by 270
Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease
Matheson, M. C. (2005) · Thorax · doi:10.1136/thx.2004.035170 · Cited by 264
Chronic mucus hypersecretion in COPD and death from pulmonary infection
Prescott, E., Lange, P., & Vestbo, J. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081333 · Cited by 260
Burgel, P.-R. (2004) · Thorax · doi:10.1136/thx.2003.018879 · Cited by 251
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
Poole, P., Black, P. N., & Cates, C. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001287.pub4 · Cited by 225
Submucosal glands and airway defense
Wine, J. J., & Joo, N. S. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.2306015 · Cited by 223
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Chong, J., Leung, B., & Poole, P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002309.pub5 · Cited by 218
Lange, P., Nyboe, J., Appleyard, M., Jensen, G., & Schnohr, P. (1990) · Thorax · doi:10.1136/thx.45.8.579 · Cited by 217
Reassessment of inflammation of airways in chronic bronchitis.
Mullen, J. B., Wright, J. L., Wiggs, B. R., Pare, P. D., & Hogg, J. C. (1985) · BMJ · doi:10.1136/bmj.291.6504.1235 · Cited by 216
Chronic Cough with a History of Excessive Sputum Production
Smyrnios, N. A., Irwin, R. S., & Curley, F. J. (1995) · Chest · doi:10.1378/chest.108.4.991 · Cited by 214
New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease
Kim, V., Rogers, T. J., & Criner, G. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200802-014et · Cited by 207
Self-citationPelkonen, M., Notkola, I.-L., Nissinen, A., Tukiainen, H., & Koskela, H. (2006) · Chest · doi:10.1378/chest.130.4.1129 · Cited by 203
van Noord, J. A., Aumann, J. L., Janssens, E., Verhaert, J., Smeets, J. J., Mueller, A., & Cornelissen, P. J. G. (2006) · Chest · doi:10.1378/chest.129.3.509 · Cited by 203
The epithelial cholinergic system of the airways
Kummer, W., Lips, K. S., & Pfeil, U. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0455-2 · Cited by 200
The Spirometric Efficacy of Once-Daily Dosing With Tiotropium in Stable COPD
Casaburi, R., Briggs, D. D., Donohue, J. F., Serby, C. W., Menjoge, S. S., & Witek, T. J. (2000) · Chest · doi:10.1378/chest.118.5.1294 · Cited by 198
The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study
de Oca, M. M., Halbert, R. J., Lopez, M. V., Perez-Padilla, R., Tálamo, C., Moreno, D., Muiño, A., Jardim, J. R. B., Valdivia, G., Pertuzé, J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00141611 · Cited by 198
Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk
Guerra, S., Sherrill, D. L., Venker, C., Ceccato, C. M., Halonen, M., & Martinez, F. D. (2009) · Thorax · doi:10.1136/thx.2008.110619 · Cited by 194
Epithelial Mucin Stores Are Increased in the Large Airways of Smokers With Airflow Obstruction
Innes, A. L., Woodruff, P. G., Ferrando, R. E., Donnelly, S., Dolganov, G. M., Lazarus, S. C., & Fahy, J. V. (2006) · Chest · doi:10.1378/chest.130.4.1102 · Cited by 182
Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.
Verra, F., Escudier, E., Lebargy, F., Bernaudin, J. F., De Crémoux, H., & Bignon, J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.3.7881648 · Cited by 172
Longitudinal Lung Function Decline in Subjects with Respiratory Symptoms
Sherman, C. B., Xu, X., Speizer, F. E., Ferris, B. G., Weiss, S. T., & Dockery, D. W. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.4.855 · Cited by 169
Respiratory Complications of Gastroesophageal Reflux
Barish, C. F. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.10.1882 · Cited by 164
Janson, C., Chinn, S., Jarvis, D., & Burney, P. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00098701 · Cited by 164
Metalloproteinases Mediate Mucin 5AC Expression by Epidermal Growth Factor Receptor Activation
Deshmukh, H. S., Case, L. M., Wesselkamper, S. C., Borchers, M. T., Martin, L. D., Shertzer, H. G., Nadel, J. A., & Leikauf, G. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1003oc · Cited by 144
Cerveri, I., Accordini, S., Verlato, G., Corsico, A. G., Zoia, M. C., Casali, L., Burney, P., & de Marco, R. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00087101 · Cited by 144
Mucolytics, Expectorants, and Mucokinetic Medications
Rubin, B. K. (2007) · Respiratory Care · doi:10.4187/respcare.07520859 · Cited by 140
Expression of ErbB receptors and mucins in the airways of long term current smokers
O’Donnell, R. (2004) · Thorax · doi:10.1136/thx.2004.028043 · Cited by 136
DNA Methylation in Inflammatory Genes among Children with Obstructive Sleep Apnea
Kim, J., Bhattacharjee, R., Khalyfa, A., Gozal, D., Capdevila, Ó. S., Wang, Y., & Gozal, D. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-1026oc · Cited by 131
Predictors of chronic bronchitis in South African adults.
Ehrlich, R. I., White, N. W., Norman, R. E., Laubscher, R., Steyn, K., Lombard, C. J., & Bradshaw, D. (2004) · PubMed · Cited by 127
Devalia, J., Sapsford, R. J., Rusznák, C., Toumbis, M., & Davies, R. J. (1992) · Pulmonary Pharmacology · doi:10.1016/0952-0600(92)90068-r · Cited by 127
Chronic Obstructive Pulmonary Disease Mortality in Six U.S. Cities
Speizer, F. E., Fay, M. E., Dockery, D. W., & Ferris, B. G. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.3_pt_2.s49 · Cited by 127
Mullen, J. B., Wright, J. R., Wiggs, B. R., Paré, P. D., & Hogg, J. C. (1987) · Thorax · doi:10.1136/thx.42.11.843 · Cited by 126
Alternative mechanisms for tiotropium
Bateman, E. D., Rennard, S. I., Barnes, P. J., Dicpinigaitis, P. V., Gosens, R., Gross, N. J., Nadel, J. A., Pfeifer, M. A., Racké, K., Rabe, K. F., et al. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.06.002 · Cited by 124
Innes, A. L., Carrington, S. D., Thornton, D. J., Kirkham, S., Rousseau, K., Dougherty, R. H., Raymond, W. W., Caughey, G. H., Muller, S. J., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1056oc · Cited by 123
Chronic respiratory symptoms, spirometry and knowledge of COPD among general population
Miravitlles, M., de la Roza, C., Morera, J., Montemayor, T., Gobartt, E., Martín, A., & Álvarez-Sala, J. L. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.02.024 · Cited by 119
Seven-Year Cumulative Incidence of COPD in an Age-Stratified General Population Sample
Lindberg, A., Eriksson, B., Larsson, L.-G., Rönmark, E., Sandström, T., & Lundbäck, B. (2006) · CHEST Journal · doi:10.1378/chest.129.4.879 · Cited by 117
Markers of Mucus Secretion and DNA Levels in Induced Sputum from Asthmatic and from Healthy Subjects
Fahy, J. V., Steiger, D. J., Liu, J., Basbaum, C. B., Finkbeiner, W. E., & Boushey, H. A. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1132 · Cited by 116
Cough and sputum production as risk factors for poor outcomes in patients with COPD
Miravitlles, M. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.02.003 · Cited by 112
β 2 -Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model
Nguyễn, L., Lin, R. J., Parra, S., Omoluabi, O., Hanania, N. A., Tuvim, M. J., Knoll, B. J., Dickey, B. F., & Bond, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810902106 · Cited by 112
Taylor, D. R., Buick, B., Kinney, C., Lowry, R. C., & McDevitt, D. G. (1985) · PubMed · doi:10.1164/arrd.1985.131.5.747 · Cited by 103
Pallasaho, P., Lundbäck, B., Läspä, S. L., Jönsson, E., Kotaniemi, J., Sovijärvi, A. R. A., & Laitinen, L. A. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90265-2 · Cited by 102
Respiratory Risk Factors and Mortality: Longitudinal Studies in Washington County, Maryland
Tockman, M. S., & Comstock, G. W. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.3_pt_2.s56 · Cited by 96
Effects of β-agonists on airway epithelial cells
Salathe, M. A. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129412 · Cited by 91
Annesi‐Maesano, I., & Kauffmann, F. (1986) · PubMed · doi:10.1164/arrd.1986.134.4.688 · Cited by 83
Epidemiological Studies in Mucus Hypersecretion
Vestbo, J. (2002) · Novartis Foundation symposium · doi:10.1002/0470860790.ch2 · Cited by 83
Dexamethasone-Mediated Repression of MUC5AC Gene Expression in Human Lung Epithelial Cells
Chen, Y., Nickola, T. J., DiFronzo, N. L., Colberg‐Poley, A. M., & Rose, M. C. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0176oc · Cited by 82
MALIGNANT PHÆOCHROMOCYTOMA WITH FUNCTIONING METASTASES
Davis, P., Peart, W. S., & Hoff, W. V. (1955) · The Lancet · doi:10.1016/s0140-6736(55)92694-5 · Cited by 81
The Association Between Small Airway Obstruction and Emphysema Phenotypes in COPD
Kim, W. D., Ling, S., Coxson, H. O., et al. (2007) · CHEST Journal · doi:10.1378/chest.06-2194 · Cited by 70
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Chong, J., Poole, P., Leung, B., & Black, P. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002309.pub3 · Cited by 63
Holtzman, M. J., Tyner, J. W., Kim, E. Y., Lo, M. S., Patel, A. C., Shornick, L. P., Agapov, E., & Zhang, Y. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200502-015aw · Cited by 59
Effects of methylxanthines on airway mucociliary function
Wanner, A. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90082-8 · Cited by 58
The Effect of Inhaled Tiotropium Bromide on Lung Mucociliary Clearance in Patients With COPD
Hasani, A., Toms, N., Agnew, J. E., Sarno, M., Harrison, A. J., & Dilworth, J. P. (2004) · CHEST Journal · doi:10.1378/chest.125.5.1726 · Cited by 58
Sputum Changes Associated with the Use of Ipratropium Bromide
Ghafouri, M., Patil, K. D., & Kass, I. (1984) · CHEST Journal · doi:10.1378/chest.86.3.387 · Cited by 56
Small Airway Mucous Metaplasia and Inflammation in Chronic Obstructive Pulmonary Disease
Kim, V., Kelemen, S. E., Abuel‐Haija, M., Gaughan, J., Sharafkaneh, A., Evans, C. M., Dickey, B. F., Solomides, C., Rogers, T. J., & Criner, G. J. (2008) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802522445 · Cited by 44
Self-citationChronic obstructive pulmonary disease in the absence of chronic bronchitis in China
Lu, M., Yao, W.-Z., Zhong, N., Zhou, Y., Wang, C., Chen, P., Kang, J., Huang, S., Chen, B.-Y., Wang, C., et al. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01817.x · Cited by 36
Small Airway Morphometry and Improvement in Pulmonary Function after Lung Volume Reduction Surgery
Kim, V., Criner, G. J., Abdallah, H. Y., Gaughan, J. P., Furukawa, S., & Solomides, C. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-659oc · Cited by 36
Self-citationReversibility of Airways Injury over a 12-Month Period following Smoking Cessation
Swan, G. E., Hodgkin, J. E., Roby, T. J., Mittman, C., Jacobo, N., & Peters, J. M. (1992) · CHEST Journal · doi:10.1378/chest.101.3.607 · Cited by 35
Chronic cough and sputum production: a clinical COPD phenotype?: Table 1–
Burgel, P. (2012) · European Respiratory Journal · doi:10.1183/09031936.00022412 · Cited by 35
Valderramas, S., & Atallah, Á. N. (2009) · Respiratory Care · doi:10.4187/respcare.09540327 · Cited by 28
The Effect of Chronic Sputum Production on Respiratory Symptoms in Severe COPD
Kim, V., Garfield, J. L., Grabianowski, C. L., Krahnke, J. S., Gaughan, J., Jacobs, M. R., & Criner, G. J. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.558546 · Cited by 21
Self-citation
Cited by
Wallace, T. C., Bailey, R. L., Blumberg, J. B., Burton-Freeman, B., Chen, C.-Y. O., Crowe-White, K. M., Drewnowski, A., Hooshmand, S., Johnson, E., Lewis, R., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1632258 · Cited by 638
Mehta, M., Dhanjal, D. S., Paudel, K. R., Singh, B., Gupta, G., Rajeshkumar, S., Thangavelu, L., Tambuwala, M. M., Bakshi, H. A., Chellappan, D. K., et al. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00698-3 · Cited by 330
Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD
Raby, K. L., Michaeloudes, C., Tonkin, J., Chung, K. F., & Bhavsar, P. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1201658 · Cited by 260
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
Kärkkäinen, M., Kettunen, H.-P., Nurmi, H., Selander, T., Purokivi, M., & Kaarteenaho, R. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0996-2 · Cited by 23
Cigarette Smoke Particle-Induced Lung Injury and Iron Homeostasis
Ghio, A. J., Pavlisko, E. N., Roggli, V. L., Todd, N. W., & Sangani, R. G. (2022) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s337354 · Cited by 19
Metadata
- Authors
- Kim, V., & Criner, G. J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02-01
- Volume
- 187
- Issue
- 3
- Pages
- 228-237
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2143763541
- Cited by
- 513
- References
- 97
- FWCI
- 13.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.